Shannon entropy: A novel parameter for quantifying pentagon copying performance in non-demented Parkinson's disease patients

. 2022 Jan ; 94 () : 45-48. [epub] 20211204

Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid34883358

INTRODUCTION: Impaired copy of intersecting pentagons from the Mini-Mental State Examination (MMSE), has been used to assess dementia in Parkinson's disease (PD). We used a digitizing tablet during the pentagon copying test (PCT) as a potential tool for evaluating early cognitive deficits in PD without major cognitive impairment. We also aimed to uncover the neural correlates of the identified parameters using whole-brain magnetic resonance imaging (MRI). METHODS: We enrolled 27 patients with PD without major cognitive impairment and 25 age-matched healthy controls (HC). We focused on drawing parameters using a digitizing tablet. Parameters with between-group differences were correlated with cognitive outcomes and were used as covariates in the whole-brain voxel-wise analysis using voxel-based morphometry; familywise error (FWE) threshold p < 0.001. RESULTS: PD patients differed from HC in attention domain z-scores (p < 0.0001). In terms of tablet parameters, the groups differed in Shannon entropy (horizontal in-air, p = 0.003), which quantifies the movements between two strokes. In PD, a correlation was found between the median of Shannon entropy (horizontal in-air) and attention z-scores (R = -0.55, p = 0.006). The VBM revealed an association between our drawing parameter of interest and gray matter (GM) volume variability in the right superior parietal lobe (SPL). CONCLUSION: Using a digitizing tablet during the PCT, we identified a novel entropy-based parameter that differed between the nondemented PD and HC groups. This in-air parameter correlated with the level of attention and was linked to GM volume variability of the region engaged in spatial attention.

Zobrazit více v PubMed

Ferrazzoli D., Ortelli P., Madeo G., Giladi N., Petzinger G.M., Frazzitta G. Basal ganglia and beyond: the interplay between motor and cognitive aspects in Parkinson's disease rehabilitation. Neurosci. Biobehav. Rev. 2018;90:294–308. doi: 10.1016/j.neubiorev.2018.05.007. PubMed DOI

Yarnall A., Rochester L., Burn D.J. The interplay of cholinergic function, attention, and falls in Parkinson's disease. Mov. Disord. 2011;26:2496–2503. doi: 10.1002/MDS.23932. PubMed DOI

Litvan I., Goldman J.G., Tröster A.I., Schmand B.A., Weintraub D., Petersen R.C., Mollenhauer B., Adler C.H., Marder K., Williams-Gray C.H., Aarsland D., Kulisevsky J., Rodriguez-Oroz M.C., Burn D.J., Barker R.A., Emre M. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement Disorder Society Task Force guidelines. Mov. Disord. 2012;27:349–356. doi: 10.1002/mds.24893. PubMed DOI PMC

Williams-Gray C.H., Mason S.L., Evans J.R., Foltynie T., Brayne C., Robbins T.W., Barker R.A. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. J. Neurol. Neurosurg. Psychiatry. 2013;84:1258–1264. doi: 10.1136/jnnp-2013-305277. PubMed DOI

Filoteo J.V., Reed J.D., Litvan I., Harrington D.L. Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease. Mov. Disord. 2014;29:360–367. doi: 10.1002/mds.25633. PubMed DOI PMC

Drotár P., Mekyska J., Rektorová I., Masarová L., Smékal Z., Faundez-Zanuy M. Analysis of in-air movement in handwriting: a novel marker for Parkinson's disease. Comput. Methods Progr. Biomed. 2014;117:405–411. doi: 10.1016/j.cmpb.2014.08.007. PubMed DOI

Mucha J., Mekyska J., Galaz Z., Faundez-Zanuy M., Lopez-de-Ipina K., Zvoncak V., Kiska T., Smekal Z., Brabenec L., Rektorova I. Identification and monitoring of Parkinson's disease dysgraphia based on fractional-order derivatives of online handwriting. Appl. Sci. 2018;8:2566. doi: 10.3390/app8122566. DOI

Drotar P., Mekyska J., Rektorova I., Masarova L., Smekal Z., Faundez-Zanuy M. Decision support framework for Parkinson's disease based on novel handwriting markers. IEEE Trans. Neural Syst. Rehabil. Eng. 2015;23:508–516. doi: 10.1109/TNSRE.2014.2359997. PubMed DOI

Caffarra P., Gardini S., Dieci F., Copelli S., Maset L., Concari L., Farina E., Grossi E. The qualitative scoring MMSE pentagon test (QSPT): a new method for differentiating dementia with Lewy Body from Alzheimer's disease. Behav. Neurol. 2013;27:213–220. doi: 10.3233/BEN-120319. PubMed DOI PMC

Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage. 2007;38:95–113. doi: 10.1016/j.neuroimage.2007.07.007. PubMed DOI

Ma H.I., Hwang W.J., Chang S.H., Wang T.Y. Progressive micrographia shown in horizontal, but not vertical, writing in Parkinson's disease. Behav. Neurol. 2013;27:169–174. doi: 10.3233/BEN-120285. PubMed DOI PMC

Garcia-Diaz A.I., Segura B., Baggio H.C., Marti M.J., Valldeoriola F., Compta Y., Vendrell P., Bargallo N., Tolosa E., Junque C. Structural MRI correlates of the MMSE and pentagon copying test in Parkinson's disease. Park. Relat. Disord. 2014;20:1405–1410. doi: 10.1016/j.parkreldis.2014.10.014. PubMed DOI

Nemcova Elfmarkova N., Gajdos M., Rektorova I., Marecek R., Rapcsak S.Z. Neural evidence for defective top-down control of visual processing in Parkinson's and Alzheimer's disease. Neuropsychologia. 2017;106:236–244. doi: 10.1016/j.neuropsychologia.2017.09.034. PubMed DOI

Kunst J., Marecek R., Klobusiakova P., Balazova Z., Anderkova L., Nemcova-Elfmarkova N., Rektorova I. Patterns of grey matter atrophy at different stages of Parkinson's and Alzheimer's diseases and relation to cognition. Brain Topogr. 2019;32:142–160. doi: 10.1007/s10548-018-0675-2. PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...